With ever more life sciences graduates coming on stream, job seekers also need to get creative to land their ideal role in ...

To encourage the uptake of complex therapies in clinical practice, brand teams must ensure they use data-driven insights to ...

Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

RFV was first identified in Kenya's Rift Valley around 100 years ago has been detected across much of Africa and also in the ...

In our final video from ESMO 2024, web editor Nicole Raleigh spoke with Dr Meredith McKean, a melanoma investigator at the Sarah Cannon Research Institute.

The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

Now, the FDA has added three new products to its list of medicines in short supply as a result of the plant being taken ...

In true form, BIO-Europe will mark its 30th anniversary in Stockholm, Sweden, from November 4-6, 2024. The Nordic region ...

The once-weekly injectable joins one-shot haemophilia B gene therapy Beqvez (fidanacogene elaparvovec) in Pfizer’s portfolio, ...

Novartis' Piqray/Vijoice (alpelisib) is the only PIK3CA inhibitor to have reached the market for breast cancer, having been ...

GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...

US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give ...